Download PDF
Semin Respir Crit Care Med 2016; 37(06): 876-885
DOI: 10.1055/s-0036-1592125
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Modern Diagnostic Approach to Community-Acquired Pneumonia in Adults

James D. Chalmers
1   Scottish Centre for Respiratory Research, University of Dundee, Dundee, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
13 December 2016 (online)

    Permissions and Reprints

Abstract

Respiratory tract infections, the majority of which are community acquired, are among the leading causes of death worldwide and a leading indication for hospital admission. The burden of disease demonstrates a “U”-shaped distribution, primarily affecting young children as the immune system matures, and older adults as the process of immunosenescence and accumulation of comorbidities leads to increased susceptibility to infection. Diagnosis of community-acquired pneumonia (CAP) is traditionally based on demonstration of a new infiltrate on a chest radiograph in a patient presenting with an acute respiratory illness or sepsis. Advances in diagnosis have been slow, and although there are increasing data on the value of computed tomography or lung ultrasound as more sensitive diagnostic methodologies, they are not widely used as initial diagnostic tests. There are a wide range of differential diagnoses and pneumonia “mimics” which should be considered in patients presenting with CAP. Once the diagnosis of CAP has been made, identifying the causative microorganism is the next stage in the diagnostic process. Traditional culture-based approaches are relatively insensitive and achieve a positive diagnosis in only 30 to 70% of cases, even when rigorously applied. Urinary antigen tests, polymerase chain reaction assays, and even next-generation sequencing technologies have become available and are increasing the rates of positive diagnosis. In an era of increasing antimicrobial resistance, the accurate diagnosis of CAP and determining the causative pathogen are ever more important. Getting these both right is key in reducing both morbidity and mortality from CAP, and appropriate antimicrobial stewardship which is now an international healthcare priority.

Keywords

chest radiograph - community-acquired pneumonia - epidemiology - microbiology - polymerase chain reaction - risk factors - Streptococcus pneumoniae
 

  • References

  • 1 Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect 2014; 20 (Suppl. 05) 45-51
    CrossrefPubMedGoogle Scholar
  • 2 Lozano R, Naghavi M, Foreman K , et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859) 2095-2128
    CrossrefPubMedGoogle Scholar
  • 3 Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007; 131 (6) 1865-1869
    CrossrefPubMedGoogle Scholar
  • 4 Taylor JK, Fleming GB, Singanayagam A, Hill AT, Chalmers JD. Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med 2013; 126 (11) 995-1001
    CrossrefPubMedGoogle Scholar
  • 5 Teepe J, Little P, Elshof N , et al; GRACE consortium. Amoxicillin for clinically unsuspected pneumonia in primary care: subgroup analysis. Eur Respir J 2016; 47 (1) 327-330
    CrossrefPubMedGoogle Scholar
  • 6 Macfarlane J. Lower respiratory tract infection and pneumonia in the community. Semin Respir Infect 1999; 14 (2) 151-162
    PubMedGoogle Scholar
  • 7 Akram AR, Chalmers JD, Hill AT. Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia. QJM 2011; 104 (10) 871-879
    CrossrefPubMedGoogle Scholar
  • 8 Lim HF, Phua J, Mukhopadhyay A , et al. IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia. Eur Respir J 2014; 43 (3) 852-862
    CrossrefPubMedGoogle Scholar
  • 9 Salih W, Schembri S, Chalmers JD. Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data. Eur Respir J 2014; 43 (3) 842-851
    CrossrefPubMedGoogle Scholar
  • 10 Liapikou A, Cillóniz C, Gabarrús A , et al. Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia. Eur Respir J 2016; 48 (1) 257-261
    CrossrefPubMedGoogle Scholar
  • 11 Sterrantino C, Trifirò G, Lapi F , et al. Burden of community-acquired pneumonia in Italian general practice. Eur Respir J 2013; 42 (6) 1739-1742
    CrossrefPubMedGoogle Scholar
  • 12 Chalmers JD, Hill AT. Investigation of “non-responding” presumed lower respiratory tract infection in primary care. BMJ 2011; 343: d5840
    CrossrefPubMedGoogle Scholar
  • 13 Singanayagam A, Chalmers JD. Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia. Lancet Respir Med 2013; 1 (8) 653-662
    CrossrefPubMedGoogle Scholar
  • 14 Postma DF, van Werkhoven CH, van Elden LJ , et al; CAP-START Study Group. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 2015; 372 (14) 1312-1323
    CrossrefPubMedGoogle Scholar
  • 15 Carugati M, Franzetti F, Wiemken T , et al. De-escalation therapy among bacteraemic patients with community-acquired pneumonia. Clin Microbiol Infect 2015; 21 (10) 936.e11-936.e18
    CrossrefPubMedGoogle Scholar
  • 16 Aliberti S, Cilloniz C, Chalmers JD , et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax 2013; 68 (11) 997-999
    CrossrefPubMedGoogle Scholar
  • 17 Mandell LA, Wunderink RG, Anzueto A , et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl. 02) S27-S72
    CrossrefPubMedGoogle Scholar
  • 18 Mandal P, Chalmers JD, Choudhury G, Akram AR, Hill AT. Vascular complications are associated with poor outcome in community-acquired pneumonia. QJM 2011; 104 (6) 489-495
    CrossrefPubMedGoogle Scholar
  • 19 American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171 (4) 388-416
    CrossrefPubMedGoogle Scholar
  • 20 Chalmers JD, Taylor JK, Singanayagam A , et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011; 53 (2) 107-113
    CrossrefPubMedGoogle Scholar
  • 21 Aliberti S, Di Pasquale M, Zanaboni AM , et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012; 54 (4) 470-478
    CrossrefPubMedGoogle Scholar
  • 22 Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67 (1) 71-79
    CrossrefPubMedGoogle Scholar
  • 23 Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 2014; 58 (3) 330-339
    CrossrefPubMedGoogle Scholar
  • 24 Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128 (6) 3854-3862
    CrossrefPubMedGoogle Scholar
  • 25 Cilloniz C, Torres A, Polverino E , et al. Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome. Eur Respir J 2014; 43 (6) 1698-1708
    CrossrefPubMedGoogle Scholar
  • 26 Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10 (4) 279-287
    CrossrefPubMedGoogle Scholar
  • 27 Rossouw TM, Anderson R, Feldman C. Impact of HIV infection and smoking on lung immunity and related disorders. Eur Respir J 2015; 46 (6) 1781-1795
    CrossrefPubMedGoogle Scholar
  • 28 Ewig S, Klapdor B, Pletz MW , et al; CAPNETZ Study Group. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax 2012; 67 (2) 132-138
    CrossrefPubMedGoogle Scholar
  • 29 Polverino E, Dambrava P, Cillóniz C , et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010; 65 (4) 354-359
    CrossrefPubMedGoogle Scholar
  • 30 Self WH, Wunderink RG, Williams DJ , et al. Staphylococcus aureus community-acquired pneumonia. Prevalence, clinical characteristics and outcomes. Clin Infect Dis 2016; 63 (3) 300-309
    CrossrefPubMedGoogle Scholar
  • 31 Jones BE, Jones MM, Huttner B , et al. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 Medical Centers, 2006–2010. Clin Infect Dis 2015; 61 (9) 1403-1410
    CrossrefPubMedGoogle Scholar
  • 32 Dobler CC, Waterer G. Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too?. Respirology 2013; 18 (6) 923-932
    CrossrefPubMedGoogle Scholar
  • 33 Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008; 168 (20) 2205-2210
    CrossrefPubMedGoogle Scholar
  • 34 Prina E, Ranzani OT, Polverino E , et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Ann Am Thorac Soc 2015; 12 (2) 153-160
    PubMedGoogle Scholar
  • 35 Jeong BH, Koh WJ, Yoo H , et al. Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital. Respiration 2014; 88 (3) 190-198
    CrossrefPubMedGoogle Scholar
  • 36 Campbell SG, Murray DD, Hawass A, Urquhart D, Ackroyd-Stolarz S, Maxwell D. Agreement between emergency physician diagnosis and radiologist reports in patients discharged from an emergency department with community-acquired pneumonia. Emerg Radiol 2005; 11 (4) 242-246
    CrossrefPubMedGoogle Scholar
  • 37 Chandra A, Nicks B, Maniago E, Nouh A, Limkakeng A. A multicenter analysis of the ED diagnosis of pneumonia. Am J Emerg Med 2010; 28 (8) 862-865
    CrossrefPubMedGoogle Scholar
  • 38 Claessens YE, Debray MP, Tubach F , et al. Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med 2015; 192 (8) 974-982
    CrossrefPubMedGoogle Scholar
  • 39 Gonçalves-Pereira J, Conceição C, Póvoa P. Community-acquired pneumonia: identification and evaluation of nonresponders. Ther Adv Infect Dis 2013; 1 (1) 5-17
    PubMedGoogle Scholar
  • 40 Bhatnagar R, Corcoran JP, Maldonado F , et al. Advanced medical interventions in pleural disease. Eur Respir Rev 2016; 25 (140) 199-213
    CrossrefPubMedGoogle Scholar
  • 41 Reali F, Sferrazza Papa GF, Carlucci P , et al. Can lung ultrasound replace chest radiography for the diagnosis of pneumonia in hospitalized children?. Respiration 2014; 88 (2) 112-115
    CrossrefPubMedGoogle Scholar
  • 42 Ye X, Xiao H, Chen B, Zhang S. Accuracy of lung ultrasonography versus chest radiography for the diagnosis of adult community-acquired pneumonia: review of the literature and meta-analysis. PLoS ONE 2015; 10 (6) e0130066
    CrossrefPubMedGoogle Scholar
  • 43 Reissig A, Copetti R, Mathis G , et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012; 142 (4) 965-972
    CrossrefPubMedGoogle Scholar
  • 44 Chavez MA, Shams N, Ellington LE , et al. Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir Res 2014; 15: 50
    CrossrefPubMedGoogle Scholar
  • 45 Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008; 121 (3) 219-225
    CrossrefPubMedGoogle Scholar
  • 46 Chalmers JD, Singanayagam A, Scally C, Hill AT. Admission D-dimer can identify low-risk patients with community-acquired pneumonia. Ann Emerg Med 2009; 53 (5) 633-638
    CrossrefPubMedGoogle Scholar
  • 47 Llor C, Bjerrum L. Antibiotic prescribing for acute bronchitis. Expert Rev Anti Infect Ther 2016; 14 (7) 633-642
    CrossrefPubMedGoogle Scholar
  • 48 Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013; 10 (2) 81-89
    PubMedGoogle Scholar
  • 49 Mao B, Yang JW, Lu HW, Xu JF. Asthma and bronchiectasis exacerbation. Eur Respir J 2016; 47 (6) 1680-1686
    CrossrefPubMedGoogle Scholar
  • 50 Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J 2015; 45 (5) 1446-1462
    CrossrefPubMedGoogle Scholar
  • 51 Kapoor JR, Kapoor R, Ju C , et al. Precipitating clinical features, heart failure characterisation and outcomes in patients hospitalized with heart failure with reduced borderline and preserved ejection fraction. JACC Heart Fail 2016; 4 (6) 464-472
    CrossrefPubMedGoogle Scholar
  • 52 Shepshelovich D, Goldvaser H, Edel Y, Shochat T, Lahav M. High lung cancer incidence in heavy smokers following hospitalization due to pneumonia. Am J Med 2016; 129 (3) 332-338
    CrossrefPubMedGoogle Scholar
  • 53 Aliberti S, Brambilla AM, Chalmers JD , et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res 2014; 15: 27
    CrossrefPubMedGoogle Scholar
  • 54 Alves dos Santos JW, Torres A, Michel GT , et al. Non-infectious and unusual infectious mimics of community-acquired pneumonia. Respir Med 2004; 98 (6) 488-494
    CrossrefPubMedGoogle Scholar
  • 55 Bonaccorsi A, Cancellieri A, Chilosi M , et al. Acute interstitial pneumonia: report of a series. Eur Respir J 2003; 21 (1) 187-191
    CrossrefPubMedGoogle Scholar
  • 56 Kastelik JA, Greenstone M, McGivern DV, Morice AH. Cryptogenic organising pneumonia. Eur Respir J 2006; 28 (6) 1291
    CrossrefPubMedGoogle Scholar
  • 57 Oyama Y, Fujisawa T, Hashimoto D , et al. Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia. Eur Respir J 2015; 45 (6) 1624-1631
    CrossrefPubMedGoogle Scholar
  • 58 Rhee CK, Min KH, Yim NY , et al. Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J 2013; 41 (2) 402-409
    CrossrefPubMedGoogle Scholar
  • 59 Kuroyama M, Kagawa H, Kitada S, Maekura R, Mori M, Hirano H. Exogenous lipoid pneumonia caused by repeated sesame oil pulling: a report of two cases. BMC Pulm Med 2015; 15: 135
    CrossrefPubMedGoogle Scholar
  • 60 Wang JY, Lee CH, Yu MC, Lee MC, Lee LN, Wang JT. Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study. Eur Respir J 2015; 46 (2) 567-570
    CrossrefPubMedGoogle Scholar
  • 61 Tang KL, Eurich DT, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Incidence, correlates, and chest radiographic yield of new lung cancer diagnosis in 3398 patients with pneumonia. Arch Intern Med 2011; 171 (13) 1193-1198
    CrossrefPubMedGoogle Scholar
  • 62 Mortensen EM, Copeland LA, Pugh MJ , et al. Diagnosis of pulmonary malignancy after hospitalization for pneumonia. Am J Med 2010; 123 (1) 66-71
    CrossrefPubMedGoogle Scholar
  • 63 Goossens H, Little P. Community acquired pneumonia in primary care. BMJ 2006; 332 (7549) 1045-1046
    CrossrefPubMedGoogle Scholar
  • 64 van Vugt SF, Broekhuizen BD, Lammens C , et al; GRACE consortium. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 2013; 346: f2450
    CrossrefPubMedGoogle Scholar
  • 65 Little P, Stuart B, Moore M , et al; GRACE consortium. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013; 13 (2) 123-129
    CrossrefPubMedGoogle Scholar
  • 66 Eccles S, Pincus C, Higgins B, Woodhead M ; Guideline Development Group. Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance. BMJ 2014; 349: g6722
    CrossrefPubMedGoogle Scholar
  • 67 Little P, Stuart B, Francis N , et al; GRACE consortium. Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 2013; 382 (9899) 1175-1182
    CrossrefPubMedGoogle Scholar
  • 68 Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009; 338: b1374
    CrossrefPubMedGoogle Scholar
  • 69 Minnaard MC, van de Pol AC, Hopstaken RM , et al. C-reactive protein point-of-care testing and associated antibiotic prescribing. Fam Pract 2016; 33 (4) 408-413
    CrossrefPubMedGoogle Scholar
  • 70 Huang Y, Chen R, Wu T, Wei X, Guo A. Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. Br J Gen Pract 2013; 63 (616) e787-e794
    CrossrefPubMedGoogle Scholar
  • 71 Singanayagam A, Chalmers JD, Hill AT. Severity assessment in community-acquired pneumonia: a review. QJM 2009; 102 (6) 379-388
    CrossrefPubMedGoogle Scholar
  • 72 Choudhury G, Chalmers JD, Mandal P , et al. Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients. Eur Respir J 2011; 38 (3) 643-648
    CrossrefPubMedGoogle Scholar
  • 73 Cillóniz C, Ewig S, Polverino E , et al. Community-acquired pneumonia in outpatients: aetiology and outcomes. Eur Respir J 2012; 40 (4) 931-938
    CrossrefPubMedGoogle Scholar
  • 74 Cillóniz C, Gabarrús A, Almirall J , et al. Bacteraemia in outpatients with community-acquired pneumonia. Eur Respir J 2016; 47 (2) 654-657
    CrossrefPubMedGoogle Scholar
  • 75 Jain S, Self WH, Wunderink RG , et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med 2015; 373 (5) 415-427
    CrossrefPubMedGoogle Scholar
  • 76 Charles PG, Whitby M, Fuller AJ , et al; Australian CAP Study Collaboration. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008; 46 (10) 1513-1521
    CrossrefPubMedGoogle Scholar
  • 77 Takaki M, Nakama T, Ishida M , et al. High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance. Jpn J Infect Dis 2014; 67 (4) 269-275
    CrossrefPubMedGoogle Scholar
  • 78 Luna CM, Famiglietti A, Absi R , et al. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118 (5) 1344-1354
    CrossrefPubMedGoogle Scholar
  • 79 Galanis I, Lindstrand A, Darenberg J , et al. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J 2016; 47 (4) 1208-1218
    CrossrefPubMedGoogle Scholar
  • 80 Mangen MJ, Rozenbaum MH, Huijts SM , et al. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. Eur Respir J 2015; 46 (5) 1407-1416
    CrossrefPubMedGoogle Scholar
  • 81 Amaro R, Liapikou A, Cilloniz C , et al. Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia. Eur Respir J 2016; ••• : 10.1183/13993003.00039-2016 [Epub ahead of print]
    PubMedGoogle Scholar
  • 82 Torres A, Cillóniz C, Ferrer M , et al. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis. Eur Respir J 2015; 45 (5) 1353-1363
    CrossrefPubMedGoogle Scholar
  • 83 Chalmers JD, Akram AR, Hill AT. Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis. Eur Respir J 2011; 37 (4) 858-864
    CrossrefPubMedGoogle Scholar
  • 84 Cillóniz C, Civljak R, Nicolini A, Torres A. Polymicrobial community-acquired pneumonia: An emerging entity. Respirology 2016; 21 (1) 65-75
    CrossrefPubMedGoogle Scholar
  • 85 Arnold FW, Summersgill JT, Lajoie AS , et al; Community-Acquired Pneumonia Organization (CAPO) Investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007; 175 (10) 1086-1093
    CrossrefPubMedGoogle Scholar
  • 86 Yuan X, Liu Y, Bai C , et al. Mycoplasma pneumoniae infection is associated with subacute cough. Eur Respir J 2014; 43 (4) 1178-1181
    CrossrefPubMedGoogle Scholar
  • 87 Sligl WI, Asadi L, Eurich DT, Tjosvold L, Marrie TJ, Majumdar SR. Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis. Crit Care Med 2014; 42 (2) 420-432
    CrossrefPubMedGoogle Scholar
  • 88 Asadi L, Sligl WI, Eurich DT , et al. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. Clin Infect Dis 2012; 55 (3) 371-380
    CrossrefPubMedGoogle Scholar
  • 89 Cavallazzi R, Wiemken T, Christensen D , et al; Community-Acquired Pneumonia Organization (CAPO) Investigators. Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia. Eur Respir J 2014; 43 (1) 178-184
    CrossrefPubMedGoogle Scholar
  • 90 Burgos J, Luján M, Larrosa MN , et al. The problem of early mortality in pneumococcal pneumonia: a study of risk factors. Eur Respir J 2015; 46 (2) 561-564
    CrossrefPubMedGoogle Scholar
  • 91 Browall S, Backhaus E, Naucler P , et al. Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types. Eur Respir J 2014; 44 (6) 1646-1657
    CrossrefPubMedGoogle Scholar
  • 92 Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonisation on prognosis in adult bronchiectasis. Ann Am Thorac Soc 2015; 12 (11) 1602-1611
    PubMedGoogle Scholar
  • 93 Rodrigo-Troyano A, Suarez-Cuartin G, Peiró M , et al. Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD. Respirology 2016; . doi: 10.1111/resp.12825
    PubMedGoogle Scholar
  • 94 Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2012; 186 (7) 657-665
    CrossrefPubMedGoogle Scholar
  • 95 Sibila O, Garcia-Bellmunt L, Giner J , et al. Airway mucin 2 is decreased in patients with severe chronic obstructive pulmonary disease with bacterial colonization. Ann Am Thorac Soc 2016; 13 (5) 636-642
    PubMedGoogle Scholar
  • 96 Botelho-Nevers E, Grattard F, Viallon A , et al. Prospective evaluation of RT-PCR on sputum versus culture, urinary antigens and serology for Legionnaire's disease diagnosis. J Infect 2016; 73 (2) 123-128
    CrossrefPubMedGoogle Scholar
  • 97 Phin N, Parry-Ford F, Harrison T , et al. Epidemiology and clinical management of Legionnaires' disease. Lancet Infect Dis 2014; 14 (10) 1011-1021
    CrossrefPubMedGoogle Scholar
  • 98 Murdoch DR, Podmore RG, Anderson TP , et al. Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires' disease: a pre-post comparison study. Clin Infect Dis 2013; 57 (9) 1275-1281
    CrossrefPubMedGoogle Scholar
  • 99 Thurman KA, Walter ND, Schwartz SB , et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 2009; 48 (9) 1244-1249
    CrossrefPubMedGoogle Scholar
  • 100 Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis 2007; 44 (4) 568-576
    CrossrefPubMedGoogle Scholar
  • 101 Lee N, Leo YS, Cao B , et al. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J 2015; 45 (6) 1642-1652
    CrossrefPubMedGoogle Scholar
  • 102 Ho PL, Sin WC, Chan JF, Cheng VC, Chan KH. Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir. Eur Respir J 2014; 44 (2) 535-537
    CrossrefPubMedGoogle Scholar
  • 103 Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009; 339: b5106
    CrossrefPubMedGoogle Scholar
  • 104 Chan MC, Lee N, Ngai KL, Leung TF, Chan PK. Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children. J Clin Microbiol 2014; 52 (2) 497-501
    CrossrefPubMedGoogle Scholar
  • 105 Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 2012; 156 (7) 500-511
    CrossrefPubMedGoogle Scholar
  • 106 Lee N, Lui GC, Wong KT , et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 2013; 57 (8) 1069-1077
    CrossrefPubMedGoogle Scholar
  • 107 Lorente ML, Falguera M, Nogués A, González AR, Merino MT, Caballero MR. Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study. Thorax 2000; 55 (2) 133-137
    CrossrefPubMedGoogle Scholar
  • 108 Peters RP, de Boer RF, Schuurman T , et al. Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia. J Clin Microbiol 2009; 47 (10) 3308-3312
    CrossrefPubMedGoogle Scholar
  • 109 Rello J, Lisboa T, Lujan M , et al; DNA-Neumococo Study Group. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009; 136 (3) 832-840
    CrossrefPubMedGoogle Scholar
  • 110 Cremers AJ, Hagen F, Hermans PW, Meis JF, Ferwerda G. Diagnostic value of serum pneumococcal DNA load during invasive pneumococcal infections. Eur J Clin Microbiol Infect Dis 2014; 33 (7) 1119-1124
    CrossrefPubMedGoogle Scholar
  • 111 Resti M, Moriondo M, Cortimiglia M , et al; Italian Group for the Study of Invasive Pneumococcal Disease. Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples. Clin Infect Dis 2010; 51 (9) 1042-1049
    CrossrefPubMedGoogle Scholar
  • 112 Simpson JL, Daly J, Baines KJ , et al. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. Eur Respir J 2016; 47 (3) 792-800
    CrossrefPubMedGoogle Scholar
  • 113 Smith DJ, Badrick AC, Zakrzewski M , et al. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. Eur Respir J 2014; 44 (4) 922-930
    CrossrefPubMedGoogle Scholar
  • 114 Wang Z, Bafadhel M, Haldar K , et al. Lung microbiome dynamics in COPD exacerbations. Eur Respir J 2016; 47 (4) 1082-1092
    CrossrefPubMedGoogle Scholar
  • 115 Viasus D, Del Rio-Pertuz G, Simonetti AF , et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis. J Infect 2016; 72 (3) 273-282
    CrossrefPubMedGoogle Scholar
  • 116 Schuetz P, Christ-Crain M, Thomann R , et al; ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009; 302 (10) 1059-1066
    CrossrefPubMedGoogle Scholar
  • 117 Choudhury G, Mandal P, Singanayagam A, Akram AR, Chalmers JD, Hill AT. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis. Clin Microbiol Infect 2011; 17 (12) 1852-1858
    CrossrefPubMedGoogle Scholar
  • 118 Murray C, Shaw A, Lloyd M , et al. A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections. J Antimicrob Chemother 2014; 69 (2) 515-518
    CrossrefPubMedGoogle Scholar
  • 119 Albrich WC, Dusemund F, Bucher B , et al; ProREAL Study Team. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012; 172 (9) 715-722
    CrossrefPubMedGoogle Scholar
  • 120 Akram AR, Chalmers JD, Taylor JK, Rutherford J, Singanayagam A, Hill AT. An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia. Clin Microbiol Infect 2013; 19 (12) 1174-1180
    CrossrefPubMedGoogle Scholar
  • 121 Menéndez R, Martinez R, Reyes S , et al. Stability in community-acquired pneumonia: one step forward with markers?. Thorax 2009; 64 (11) 987-992
    CrossrefPubMedGoogle Scholar
  • 122 Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T ; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010; 182 (11) 1426-1434
    CrossrefPubMedGoogle Scholar
  • 123 Albrich WC, Dusemund F, Rüegger K , et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011; 11: 112
    CrossrefPubMedGoogle Scholar
  • 124 Chalmers JD, Al-Khairalla M, Short PM, Fardon TC, Winter JH. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. J Antimicrob Chemother 2010; 65 (4) 608-618
    CrossrefPubMedGoogle Scholar
  • 125 Chalmers JD, Akram AR, Singanayagam A, Wilcox MH, Hill AT. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia. J Infect 2016; 73 (1) 45-53
    CrossrefPubMedGoogle Scholar
  • 126 van der Eerden MM, Vlaspolder F, de Graaff CS , et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax 2005; 60 (8) 672-678
    CrossrefPubMedGoogle Scholar